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Summary
Background In 2011, WHO member states signed up to the 25 × 25 initiative, a plan to cut mortality due to non-
communicable diseases by 25% by 2025. However, socioeconomic factors influencing non-communicable diseases 
have not been included in the plan. In this study, we aimed to compare the contribution of socioeconomic status to 
mortality and years-of-life-lost with that of the 25 × 25 conventional risk factors.
Methods We did a multicohort study and meta-analysis with individual-level data from 48 independent prospective 
cohort studies with information about socioeconomic status, indexed by occupational position, 25 × 25 risk factors 
(high alcohol intake, physical inactivity, current smoking, hypertension, diabetes, and obesity), and mortality, for a 
total population of 1 751 479 (54% women) from seven high-income WHO member countries. We estimated the 
association of socioeconomic status and the 25 × 25 risk factors with all-cause mortality and cause-specific mortality by 
calculating minimally adjusted and mutually adjusted hazard ratios [HR] and 95% CIs. We also estimated the 
population attributable fraction and the years of life lost due to suboptimal risk factors.
Findings During 26·6 million person-years at risk (mean follow-up 13·3 years [SD 6·4 years]), 310 277 participants 
died. HR for the 25 × 25 risk factors and mortality varied between 1·04 (95% CI 0·98–1·11) for obesity in men and 
2 ·17 (2·06–2·29) for current smoking in men. Participants with low socioeconomic status had greater mortality 
compared with those with high socioeconomic status (HR 1·42, 95% CI 1·38–1·45 for men; 1·34, 1·28–1·39 for 
women); this association remained significant in mutually adjusted models that included the 25 × 25 factors (HR 1·26, 
1·21–1·32, men and women combined). The population attributable fraction was highest for smoking, followed by 
physical inactivity then socioeconomic status. Low socioeconomic status was associated with a 2·1-year reduction in 
life expectancy between ages 40 and 85 years, the corresponding years-of-life-lost were 0·5 years for high alcohol 
intake, 0·7 years for obesity, 3·9 years for diabetes, 1·6 years for hypertension, 2·4 years for physical inactivity, and 
4·8 years for current smoking.
Interpretation Socioeconomic circumstances, in addition to the 25 × 25 factors, should be targeted by local and global 
health strategies and health risk surveillance to reduce mortality.
Funding European Commission, Swiss State Secretariat for Education, Swiss National Science Foundation, the 
Medical Research Council, NordForsk, Portuguese Foundation for Science and Technology.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
The 2013–20 World Health Organization (WHO) Global 
Action Plan for the Prevention and Control of Non-
Communicable Diseases (NCDs) targets seven major 
risk factors, comprising the harmful use of alcohol, 
insufficient physical activity, current tobacco use, raised 
blood pressure, intake of salt or sodium, diabetes, and 
obesity (referred to as the 25 × 25 risk factors), with the 
overall aim of reducing premature mortality from non-
communicable diseases by 25% by 2025.1 Similarly, the 
Global Burden of Disease (GBD) Collaboration, the 
largest study monitoring health changes globally, 
performs an annual risk assessment of the burden of 
disease and injury attributable to 67 risk factors in 
21 world-regions.2 Despite the fact that low socioeconomic 
status is one of the strongest predictors of morbidity and 
premature mortality worldwide,3–6 poor socioeconomic 
circumstances are not considered modifiable risk factors 
in these important global health strategies.
Socioeconomic circumstances and their consequences 
are modifiable by policies at the local, national, and 
international levels,7–9 as are risk factors targeted by 
existing global health strategies. Evidence also suggests 
that the burden of most 25 × 25 risk factors is concentrated 
in lower socioeconomic groups worldwide.10,11 Inter-
ventions to reduce premature mortality attributable to 
Lancet 2017; 389: 1229–37
Published Online 
January 31, 2017 
http://dx.doi.org/10.1016/
S0140-6736(16)32380-7
This online publication has 
been corrected. The first 
corrected version first 
appeared at thelancet.com on 
February 27, 2017
See Comment page 1172
*These authors contributed 
equally to this work
†Joint last authors
‡Members are listed at end of 
paper
Institute of Social and 
Preventive Medicine and 
Departments of Psychiatry and 
Internal Medicine, Lausanne 
University Hospital, Lausanne, 
Switzerland (S Stringhini PhD, 
C Carmeli PhD, 
Prof M Bochud PhD, 
A M Lasserre MD, 
Prof M Preisig MD, 
Prof P Vollenweider MD); 
Institute of Behavioural 
Sciences, University of Helsinki, 
Helsinki, Finland 
(M Jokela PhD); Department of 
Global Health and Social 
Medicine, King’s College 
London, London, UK 
(M Avendaño PhD); Harvard T H 
Chan School of Public Health, 
Boston MA, USA (M Avendaño, 
Prof I Kawachi PhD); Global 
Research Analytics for 
Population Health, Health 
Policy and Management, 
Columbia University, New 
York, NY, USA 
(Prof P Muennig MD); MRC-PHE 
Centre for Environment and 
Health, School of Public Health, 
Department of Epidemiology 
and Biostatistics, Imperial 
College London, London, UK 
(F Guida PhD, 
M Chadeau-Hyam PhD, 
Prof P Vineis PhD); 
Epidemiology Unit, ASL TO3 
Piedmont Region, Grugliasco,
Articles
1230 www.thelancet.com   Vol 389   March 25, 2017
the 25 × 25 and other risk factors might therefore benefit 
from greater focus on socioeconomic adversity so that 
the preventive toolkit for addressing NCDs can be 
expanded. To examine this hypothesis, we collated 
individual-level data from 48 independent prospective 
cohort studies from Europe, the USA, and Australia and 
aimed to determine the population attributable fraction 
(PAF) and years of life lost (YLLs) due to low socio-
economic status and compared these with mortality and 
YLLs attributable to the 25 × 25 risk factors.
Methods
Study population
This study is part of an EC Horizon 2020 consortium, the 
Lifepath project, which includes ten cohort studies. We 
have complemented those data with publicly available 
data from 38 additional cohort studies from the Inter-
University Consortium for Political and Social Research 
and the UK Data Service. Our analyses were based on 
participants whose occupational position was assessed at 
baseline between 1965 and 2009, dependent on the study 
(appendix). The 48 studies comprised a total population 
of 1 751 479 men and women from seven WHO member 
countries (UK, France, Switzerland, Portugal, Italy, USA, 
Australia). All studies included baseline data for 
socioeconomic status and a mortality follow-up of a 
minimum of 3 years. Each study was approved by the 
relevant local or national ethics committees and all 
participants gave informed consent to participate. We 
assessed the quality of included studies using the 
Cochrane Risk of Bias Tool for cohort studies.12 We 
analysed a selection of exposed and non-exposed groups, 
assessment of exposure, exclusion of the outcome of 
interest at study baseline, adjustment for con founding 
variables, assessment of confounding variables, 
assessment of outcome, and adequacy of the follow-up. 
Two reviewers (SS and MK) independently assessed the 
studies. The quality of the study was judged as high if all 
domains were assessed favourably (appendix).
Definitions and data collection
Our measure of socioeconomic status is a social class 
measure based on an individual’s last known 
occupational title at study enrolment, coded into the 
European Socio-economic Classification (ESEC). This 
variable was predefined and harmonised across the 
study cohorts before statistical analyses were done. 
Occupational position was categorised as high (higher 
professionals and managers, higher clerical, services, 
and sales workers [ESEC class 1, 2, and 3]), intermediate 
(small employers and self-employed, farmers, lower 
supervisors, and technicians [ESEC class 4, 5, and 6]), or 
low (lower clerical, services and sales workers, skilled 
workers, and semi-skilled and unskilled workers [ESEC 
class 7, 8, and 9]). For one study (E3N), occupational 
position was current occupation 2 years after baseline. 
We used ESEC as a classification because it eliminates 
the need to adjust for differences in earnings and 
standards of living across different national contexts. We 
used individual’s occupational class only because most 
cohorts did not collect information about partner’s 
occupation. This decision could have led to some 
misclassification of socioeconomic status particularly for 
older women with low labour force participation rates.
Each 25 × 25 risk factor comprised two or three 
categories to allow a balanced comparison with socio-
economic status, which was grouped into three categories 
(appendix). Self-reported smoking was categorised into 
current smoker, former smoker, and never smoked. 
Alcohol consumption was measured in alcohol units per 
week and participants were categorised as abstainers 
(0 units per week), moderate (1–21 units per week for 
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Research in context
Evidence before this study
Low socioeconomic status is one of the strongest predictors of 
morbidity and premature mortality worldwide. However, global 
health strategies do not consider poor socioeconomic 
circumstances as modifiable risk factors. The WHO Global Action 
Plan for the Prevention and Control of Non-Communicable 
Diseases, for example, targets seven major health risk factors, 
including insufficient physical activity, current tobacco use. and 
raised blood pressure, for reducing premature mortality from 
non-communicable diseases by 25% by 2025. Low socioeconomic 
status is not included among the 25 × 25 risk factors.
Added value of this study
We used data from more than 1·7 million individuals in 
48 independent cohort studies from seven countries, and 
found that the independent association between 
socioeconomic status and mortality is comparable in strength 
and consistency to those of six 25 × 25 risk factors (tobacco use, 
alcohol consumption, insufficient physical activity, raised blood 
pressure, obesity, diabetes). Our study is one of the largest 
studies to date to examine the association between 
socioeconomic status and premature mortality and the first 
large-scale investigation to directly compare the importance of 
socioeconomic circumstances as determinants of health with 
six major risk factors targeted in global health strategies for the 
reduction of premature mortality.
Implications of all the available evidence
By showing comparable health impact of low socioeconomic 
status to that of major risk factors, our study suggests that 
socioeconomic adversity should be included as a modifiable risk 
factor in local and global health strategies, policies, and 
health-risk surveillance.
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men, 1–14 per week for women), or heavy (>21 units per 
week for men, >14 per week for women) drinkers. 
Although physical activity was measured with different 
questions in each study, a dichotomised variable 
indicating the presence or absence of physical activity 
was defined (appendix). Body-mass index (BMI) was 
categorised as normal (18·5–<25 kg/m²), overweight 
(25–<30 kg/m²), or obese (≥30 kg/m²). Hypertension 
was defined as the presence of at least one of the 
following conditions: systolic blood pressure more than 
140 mm Hg, diastolic blood pressure more than 
90 mm Hg, current intake of anti-hypertensive 
medication, or self-reported hyper tension. Diabetes was 
defined as the presence of at least one of the following 
conditions: fasting glucose more than 7 mmol/L, 2 h 
post-load glucose above 11·1 mmol/L, glycated 
haemoglobin A1c more than 6·5%, or self-reported 
diabetes. Data for salt intake were only available from 
less than a third of the cohort studies; we therefore 
omitted this risk factor from our analysis.
We considered age, sex, race or ethnicity, and marital 
status as potential confounders. Race or ethnicity was 
categorised as white and non-white individuals. Marital 
status was categorised as married or cohabiting versus 
living alone.
Participants were linked to national mortality registries 
that provided information about vital status with the 
exception of the COLAUS study in which vital status was 
ascertained through active follow-up. Mean follow-up for 
mortality ranged between 3·2 years in the National 
Health Interview Survey 2009, and 27·0 years in men and 
29·5 years in women of the Alameda County Study 1965, 
with a mean across cohorts of 13·3 years [SD 6·4 years]. 
All-cause mortality, cancer mortality, cardio vascular 
disease mortality, and mortality from other causes of 
death were examined separately. We focus on cancer and 
cardiovascular disease as these diseases are the most 
common causes of death in our samples. We used codes 
from the International Classification of Diseases, 10th 
Revision (ICD-10) to define cancer (C00–C97) and 
cardiovascular disease (I00–I99) mortality. Other causes 
of death include all remaining deaths not classified as 
cancer or cardiovascular disease.
Statistical analysis
Analyses were first performed separately in each study; 
estimates were subsequently combined in a meta-
analytical framework. In study-specific analyses, we 
considered the maximum number of participants 
without missing values for each exposure. To estimate 
the association between risk factors and mortality, hazard 
ratios (HR) and 95% CIs were generated using flexible 
parametric survival models on the cumulative hazards 
scale,13 which, in addition to the HRs, allow direct 
estimation of the conditional cumulative hazard function. 
Within these models, we used restricted cubic splines 
with 0 to 4 (depending on the cohort) internal knots to 
model the baseline hazard using age as the timescale. 
Separate models were fitted for men and women and 
included marital status and race or ethnicity (minimally 
adjusted models). To check for the proportional hazard 
assumption, we performed tests based on Schoenfeld 
residuals and inspected log-log plots of Kaplan-Meier 
curves. Age stratification in 5-year intervals was 
conducted in all cohorts as a sensitivity analysis to adjust 
for age calendar effects (results not shown).
In further analyses combining men and women, we 
examined the association of socioeconomic status with 
cause-specific mortality before and after adjustment for 
the 25 × 25 risk factors. The mutually adjusted models 
included age, sex, race or ethnicity, marital status, 
socioeconomic status, and all 25 × 25 risk factors as 
independent variables with total mortality and deaths 
from cardiovascular disease, cancer, and other causes as 
outcomes. To enable balanced comparisons between 
socioeconomic status and 25 × 25 risk factors as 
predictors of cause-specific mortality, these analyses 
were restricted to a subgroup of participants with 
complete data for socioeconomic status and the 
25 × 25 risk factors.
To examine whether the association between socio-
economic status and mortality is attributable to the 
higher prevalence of the 25 × 25 risk factors among low 
socioeconomic status individuals, we repeated the 
analyses in a subgroup of participants without any 
25 × 25 risk factors. Analyses were also repeated 
specifically focusing on premature mortality (<70 years) 
and by restricting the population to cohorts in which 
height and weight as well as blood pressure were 
measured objectively using standard procedures.
To further evaluate the effects of socioeconomic status 
and the 25 × 25 risk factors on mortality, we computed the 
population attributable fraction. The population 
attributable fraction is based on the HR and the 
proportion of participants exposed assuming the 
association between exposure and outcome is causal.14 
The variance of population attributable fraction was 
estimated via bootstrapping using 1000 independent 
replications. The proportion of participants exposed 
(prevalence) was calculated as the mean prevalence 
across all cohorts for each risk factor.
YLLs were calculated as the difference of the areas 
under the survival curves (from age 40 years to 85 years) 
comparing the population exposed to a given risk factor 
with the reference population with no exposure. Area 
under the curve was computed via numerical integration 
with a spline-based method. Life expectancies were 
estimated conditional on survival to age 40 years. In view 
of the truncation at age 85 years, the theoretical maximal 
life expectancy at 40 years old is 45 years. Variance 
of YLLs was estimated via bootstrapping using 
1000 independent replications.
Study-specific HRs, PAF, and YLLs estimates were 
meta-analysed using the Hartung-Knapp random-effects 
For more on the Lifepath 
project see http://www.
lifepathproject.eu/
For more on ESEC see https://
www.iser.essex.ac.uk/archives/
esec/user-guide
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method.15 To assess heterogeneity between cohorts, we 
computed I² and τ² statistics; I² to assess heterogeneity 
attributable to variation in the true association and τ² to 
measure the inter-cohort variance. To account for τ² in 
the uncertainty around the pooled estimates, we further 
calculated 95% prediction intervals for hazard ratios.16
Role of the funding source
The funding sources had no role in the study design; in 
the collection, analysis, and interpretation of data; in the 
writing of the report; or in the decision to submit the 
paper for publication. CC and MJ had full access to the 
datasets. SS, PV, and MK had final responsibility for the 
decision to submit for publication.
Results
48 studies were included (appendix). After excluding 
27 392 (1·5%) of 1 778 871 participants who had missing 
data for the covariates or mortality, 1 751 479 participants 
were included in the analysis (appendix). Mean age at 
study entry was 47·8 years (SD 14·8) and 54% of 
participants were women. The proportion of par-
ticipants with low occupational position ranged from 
6·9% to 66·9% across studies (mean 41·4% [SD 12·5] 
for men and 27·1% [SD 14·9] for women). The 
proportion of people with a high occupational position 
varied between 5·9% and 84·8% (mean 32·5% [SD 
11·7] men and 26·1% [SD 12·3] women). Age 
stratification revealed no age calendar effects (data not 
shown).
During 12 025 208 person-years at risk for men, 
161 524 men died; during 14 580 862 person-years at risk 
for women, a total of 148 753 women died (mean follow-
up for men and women 13·3 years [SD 3·4]). In men, 
43 765 (15·2% of total) with low occupational position 
died and 17 160 (11·5%) with high occupational position 
died. In women, 11 835 (9·4% of total) with low 
occupational position died and 8292 (6·8%) with high 
occupational position died. Participants with low 
occupational position had a higher mortality risk than 
did those with high occupational position, in both men 
(HR 1·42, 95% CI 1·38–1·45; figure 1) and women 
(1·34, 1·28–1·39; figure 2). Participants with inter-
mediate occupational position had a higher mortality 
risk compared with participants with high occupational 
position (meta-analytic HR 1·21, 95% CI 1·18–1·24 for 
men and 1·17, 1·12–1·22 for women). A graded 
association between occupational position and mortality 
was observed in both men and women (HR for one unit 
decrease in SES 1·19, 95% CI 1·17–1·20 in men and 
1·15, 1·13–1·18 in women, p<0·0001 for both). 
Heterogeneity in study-specific estimates was low for 
men (I²=14·5% [0–41%], p=0·2034, τ²=0·0008) and 
moderate for women (I²=29·8% [0–51·2%], p=0·0309, 
τ²=0·0048).
Figure 3 shows mortality associated with the 25 × 25 risk 
factors (minimally adjusted models). The greatest 
increases in mortality associated with the 25 × 25 risk 
factors were for current smoking and diabetes, although 
physical inactivity, high alcohol intake, and hypertension 
were also associated (figure 3). The effect of low 
occupational position appeared greater than that of 
hypertension or obesity (figure 3); the effect of low 
occupational position on mortality was greater than that 
of obesity even when the obesity analysis was restricted 
to cohorts with a mean follow-up more than 10 years 
(>10 years; HR 1·12, 95% CI 1·05–1·21 for men and 1·24, 
1·18–1·31 for women). 33 of 48 studies had complete 
data for occupational position and all 25 × 25 risk factors 
HR (95% CI) WeightMean 
follow-up (years)
Deaths
COLAUS
NHIS 2009
NHIS 2008
MIDUS
EPIPORTO
NHIS 2007
NCDS
NHIS 2006
NHANES 2007
NHANES 2005
NHIS 2005
NHIS 2003
WLSS
NHIS 2002
NHANES 2003
NHIS 2001
NHANES 1999
NHANES 2001
WLSG
NHANES II
NHIS 2000
NHIS 1999
NHANES III
WHITEHALL II
NHIS 1998
EPIC Italy
NHIS 1997
ELSA
NHIS 2004
NHANES I
NHIS 1996
HRS
HALS
Alameda County
GAZEL
NHIS 1995
NHIS 1994
NHIS 1993
NHIS 1986
NHIS 1992
NHIS 1991
NHIS 1990
NHIS 1989
NHIS 1988
NHIS 1987
WHIP
Pooled HR
Prediction interval
I²=14·5%, τ²=0·0008
55
86
111
133
144
148
159
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234
290
291
360
372
381
463
479
483
502
528
530
540
656
708
719
758
829
840
1115
1147
1247
1279
1359
1547
1935
2293
3029
3090
3331
3898
4152
4590
4848
5564
6018
21 049
 0·1%
 0·2%
 0·2%
 0·3%
 0·2%
 0·3%
 0·3%
 0·4%
 0·4%
 0·5%
 0·5%
 0·6%
 0·9%
 0·7%
 0·9%
 0·9%
 1·0%
 1·1%
 1·2%
 1·0%
 1·1%
 1·1%
 1·2%
 0·7%
 1·5%
 0·6%
 1·7%
 1·5%
 2·1%
 1·9%
 2·4%
 2·4%
 2·0%
 2·4%
 2·8%
 3·9%
 4·8%
 4·9%
 5·1%
 5·7%
 6·0%
 6·3%
 6·6%
 7·1%
 7·4%
 5·0%
   100%
 6·16
 3·22
 4·18
 11·61
 6·88
 5·13
 7·45
 6·09
 3·86
 5·73
 7·00
 9·10
 12·72
 10·05
 7·39
 11·01
 10·51
 9·12
 14·95
 13·74
 11·94
 12·88
 14·47
 20·40
 13·78
 16·04
 14·73
 7·30
 8·15
 18·58
 15·45
 17·28
 20·23
 26·96
 25·34
 16·31
 17·18
 18·08
 23·69
 19·83
 19·75
 20·59
 21·41
 22·21
 22·93
 11·60
 (0·98–4·38)
 (0·72–2·11)
 (0·78–2·00)
 (0·81–1·81)
 (0·94–2·86)
 (0·85–1·99)
 (1·15–2·64)
 (1·29–2·58)
 (0·85–1·73)
 (0·85–1·60)
 (0·80–1·48)
 (0·86–1·50)
 (1·04–1·65)
 (1·47–2·47)
 (0·94–1·49)
 (1·49–2·39)
 (1·07–1·66)
 (1·19–1·80)
 (1·23–1·82)
 (1·05–1·64)
 (1·19–1·81)
 (1·34–2·04)
 (1·14–1·69)
 (1·21–2·04)
 (1·23–1·75)
 (1·05–1·88)
 (1·23–1·70)
 (1·22–1·74)
 (1·32–1·77)
 (1·27–1·72)
 (1·36–1·78)
 (1·31–1·71)
 (1·25–1·68)
 (1·12–1·47)
 (1·48–1·90)
 (1·25–1·52)
 (1·34–1·59)
 (1·32–1·57)
 (1·29–1·53)
 (1·26–1·47)
 (1·22–1·42)
 (1·28–1·48)
 (1·31–1·50)
 (1·29–1·46)
 (1·29–1·46)
 (1·36–1·60)
 (1·38–1·45)
 1·33–1·51
 2·08
 1·23
 1·25
 1·21
 1·64
 1·30
 1·74
 1·82
 1·21
 1·17
 1·09
 1·14
 1·31
 1·90
 1·19
 1·89
 1·33
 1·46
 1·49
 1·32
 1·47
 1·66
 1·39
 1·57
 1·47
 1·40
 1·45
 1·46
 1·53
 1·48
 1·55
 1·50
 1·45
 1·29
 1·68
 1·38
 1·46
 1·44
 1·41
 1·36
 1·32
 1·37
 1·40
 1·37
 1·38
 1·47
 1·42
1·00·5 2·5
Men
Figure 1: Mortality for low versus high occupational position in men in 46 cohort studies
HRs are adjusted for age, marital status, and race or ethnicity. Pooled HR is represented with a grey diamond and 
the 95% prediction interval with a black bar. I² statistic is the percentage of between study heterogeneity; τ² 
statistic measures the inter-study variance. The prediction interval provides a predicted range for the true 
association between occupational position and mortality. HR=hazard ratio.
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and had cause-specific mortality data, for a total of 
275 973 participants with 21 923 deaths during the follow-
up (figure 4). The association between low socioeconomic 
status and mortality was consistent across causes of 
death and remained significant in the minimally adjusted 
models and the mutually adjusted models (figure 4). The 
highest minimally adjusted HR was current smoking 
(figure 4).
We assessed the PAF for socioeconomic status and the 
25 × 25 risk factors, assuming the associations with 
mortality are causal and that the risk could be reduced to 
the level of the most favourable category for each factor 
(figure 5). We estimated the achievable reduction in 
mortality during the follow-up period should the death 
risk in the whole population equate that of high 
occupational position or the reference group for each of 
the 25 × 25 risk factors. The PAF for low SES was 18·94% 
(95% CI 17·63–20·24) for men and 15·33% (12·76–17·90) 
for women. The highest PAF was for smoking for men 
(29·04%, 26·90–31·18) and for physical inactivity for 
women (23·41%, 20·42–26·39).
In men and women combined, partial life expectancy 
at 40 years was reduced by more than 2 years because of 
low socioeconomic status (figure 6). All other 
25 × 25 factors assessed were associated with decreased 
life expectancy, apart from BMI (figure 6).
Additional sensitivity analyses including only western 
European cohorts, restricting the analysis to premature 
mortality (<70 years), to a subset of participants without 
the 25 × 25 risk factors (HR for low SES vs high SES 1·26, 
95% CI 1·12–1·42), and to high quality studies or to 
cohorts with height and weight or blood pressure 
measured using standard procedures, yielded similar 
results (appendix).
Discussion
We used individual-level data from more than 1·7 million 
individuals in 48 independent cohort studies to compare 
the association of low socio economic status with 
mortality to those of six WHO 25 × 25 risk factor targets 
for the reduction of premature mortality. We found that 
the independent association between socioeconomic 
status and mortality is com parable in strength and 
consistency across countries to those for the 25 × 25 risk 
factors. Low socioeconomic status was associated with 
2·1 YLLs between ages 40 and 85 years, while the 
corresponding years of life lost were 0·5 for high alcohol 
intake, 0·7 for obesity, 3·9 for diabetes, 1·6 for hyper-
tension, 2·4 for physical inactivity and 4·8 for current 
smoking in men and women combined. These findings 
are largely consistent with previous studies,17–19 which 
used income or education as a measure of socioeconomic 
status.
The strong influence of socioeconomic factors on 
health, morbidity and mortality is well established,3,20–25 
with studies showing a widening in inequalities in 
mortality22,25 despite absolute inequalities falling in some 
countries.22,23 Our study is one of the largest to examine 
the effect of low socioeconomic status on premature 
mortality and is to our knowledge the first large-scale 
study to directly compare the importance of socio-
economic circumstances as determinants of health with 
the six major risk factors targeted in global health 
strategies for the reduction of premature mortality. The 
association between low socioeconomic status and 
premature mortality was consistent across causes of 
death, whereas the 25 × 25 risk factors were generally 
more strongly associated with cardiovascular disease 
mortality than with cancer and with mortality of 
other causes.
HR (95% CI) WeightMean 
follow-up (years)
Deaths
COLAUS
EPIPORTO
NCDS
MIDUS
NHIS 2009
NHIS 2008
NHANES 2007
NHIS 2007
NHANES 2005
NHIS 2003
NHANES II
NHIS 2006
WLSS
NHIS 2002
NHIS 2001
NHANES 2003
NHIS 2000
NHANES III
WHITEHALL II
NHIS 2005
NHANES 1999
GAZEL
WLSG
NHIS 1999
NHANES 2001
NHIS 1998
NHANES I
NHIS 1997
EPIC Italy
HRS
NHIS 1996
ELSA
Alameda County
NHIS 2004
NHIS 1995
HALS
NHIS 1994
NHIS 1993
NHIS 1986
NHIS 1992
NHIS 1991
WHIP
NHIS 1990
NHIS 1989
NHIS 1988
NHIS 1987
E3N
Pooled HR
Prediction interval
I²=29·8%, τ²=0·0048
22
68
80
91
98
120
145
153
166
177
187
219
241
250
284
294
308
322
328
339
344
367
374
390
402
446
472
496
565
686
728
736
767
1076
1307
1490
1725
1794
1864
2138
2278
2430
2598
2766
3173
3292
6621
 0·0%
 0·1%
 0·4%
 0·5%
 0·6%
 0·6%
 0·6%
 0·9%
 0·7%
 0·6%
 0·5%
 1·2%
 1·3%
 0·9%
 1·1%
 1·4%
 0·9%
 1·1%
 1·2%
 1·7%
 1·5%
 1·2%
 1·8%
 1·2%
 2·0%
 1·3%
 1·3%
 1·6%
 0·7%
 2·5%
 2·4%
 2·9%
 2·8%
 3·1%
 3·2%
 4·1%
 4·1%
 4·1%
 4·2%
 4·6%
 4·7%
 1·2%
 4·9%
 5·0%
 5·3%
 5·4%
 6·5%
   100%
 6·19
 6·42
 7·72
 11·69
 3·22
 4·20
 3·91
 5·17
 5·84
 9·16
 14·29
 6·11
 13·06
 10·13
 11·12
 7·62
 12·09
 14·57
 20·34
 7·08
 10·95
 25·81
 15·24
 13·02
 9·39
 13·96
 20·30
 14·96
 15·30
 18·50
 15·63
 7·57
 29·47
 8·23
 16·61
 21·28
 17·51
 18·43
 24·60
 20·32
 20·27
 10·60
 21·16
 22·03
 22·92
 23·82
 16·83
 (0·22–13·15)
 (0·59–10·37)
 (0·61–2·23)
 (0·63–1·86)
 (0·71–1·90)
 (1·31–3·51)
 (0·56–1·47)
 (0·80–1·79)
 (1·02–2·68)
 (0·96–2·66)
 (0·76–2·38)
 (0·96–1·91)
 (0·75–1·45)
 (1·06–2·44)
 (1·21–2·51)
 (1·05–1·99)
 (0·84–1·85)
 (1·06–2·20)
 (0·74–1·45)
 (1·06–1·86)
 (1·07–1·95)
 (0·87–1·74)
 (1·31–2·26)
 (1·23–2·44)
 (0·92–1·53)
 (0·79–1·52)
 (0·78–1·49)
 (1·20–2·15)
 (0·69–1·74)
 (1·44–2·23)
 (1·33–2·07)
 (1·08–1·60)
 (0·87–1·30)
 (1·23–1·79)
 (1·30–1·86)
 (1·36–1·82)
 (1·14–1·54)
 (1·15–1·55)
 (1·13–1·50)
 (1·13–1·47)
 (1·14–1·48)
 (0·68–1·36)
 (1·14–1·45)
 (1·04–1·32)
 (1·22–1·53)
 (1·10–1·37)
 (1·18–1·39)
 (1·28–1·39)
 1·15–1·55
 1·72
 2·47
 1·17
 1·08
 1·16
 2·14
 0·90
 1·20
 1·65
 1·60
 1·34
 1·35
 1·05
 1·61
 1·74
 1·44
 1·25
 1·53
 1·04
 1·40
 1·44
 1·23
 1·72
 1·73
 1·19
 1·10
 1·08
 1·60
 1·09
 1·79
 1·66
 1·32
 1·07
 1·48
 1·55
 1·57
 1·33
 1·34
 1·30
 1·29
 1·30
 0·96
 1·28
 1·18
 1·36
 1·23
 1·28
 1·34
1·00·5 2·5
Women
Figure 2: Mortality for low versus high occupational position in women in 47 cohort studies 
HRs are adjusted for age, marital status, and race or ethnicity. Pooled HR is represented with a grey diamond and 
the 95% prediction interval with a black bar. The prediction interval provides a predicted range for the true 
association between occupational position and mortality. HR=hazard ratio. 
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We used occupational position as a proxy of 
socioeconomic status and social circumstances in 
general. This measure is one of the most commonly 
used indicators of socioeconomic status, data for this 
indicator were widely available across the cohort studies 
included in our analysis and occupational position is 
comparable between countries. Occupational position 
also has the advantage of reducing reverse causality—we 
assessed last known occupation, which is less likely to 
change with illness than is one’s income. However, 
socio economic status is a complex factor that comprises 
several dimensions and by using a single indicator of 
socioeconomic status we might have underestimated its 
full effect on mortality. Addressing several components 
of socioeconomic status (ie, low occupational position, 
income poverty, low education) could be important for 
population health improvement.
This study has some important limitations. First, risk 
factors (ie, hypertension, physical activity, obesity, and 
diabetes) are interconnected making it difficult to 
establish their independent contribution. For example, 
low socioeconomic status might induce changes in one 
or more risk factors, but risk factors for chronic diseases 
might also reduce labour supply and earnings, thereby 
lowering socioeconomic status. Furthermore, factors 
other than those considered in the 25 × 25 list could be 
involved in the pathways between socioeconomic status 
and mortality. In view of these complex relationships, 
our estimates of the population attributable fraction, 
assuming unidirectional causal associations, should be 
interpreted with caution. Second, different measures of 
socioeconomic status can themselves be intertwined, 
and can influence risk factors for health or disease at 
different points over a person’s life. For example, 
increased educational levels might contribute to 
increased life expectancy via multiple pathways 
including better occupational position, higher income, 
less smoking, reduced occupational hazard, more 
physical activity, healthier diet, increased self-care, and 
adherence to medical treatments.26 However, the 
finding that socioeconomic status is associated with 
death risk independently of conventional risk factors 
suggests that both socioeconomic adversity and 
25 × 25 risk factors should be targeted by health 
strategies. Third, with broad two-level or three-level 
categorisations, the assessment of both socioeconomic 
status and risk factors was crude, potentially 
underestimating the strength of associations with 
mortality outcomes. However, the comparison between 
risk factors should be balanced because they were all 
measured with the same relative level of precision. The 
observed associations of smoking, physical activity, 
high alcohol intake, diabetes, and hypertension with 
mortality were comparable with those of previous 
studies.27–30 The non-significant outcome observed 
between obesity and all-cause mortality in men might 
be an underestimate due to pre-existing morbidity 
HR (95% CI)Time at risk
(years)
Deaths ParticipantsRisk factor
Low SES (reference high SES)
 Men
 Women
Current smoking (reference never smoking)
 Men
 Women
Diabetes
 Men
 Women
Physical inactivity
 Men
 Women
High alcohol intake (reference moderate alcohol intake)
 Men
 Women
Hypertension
 Men
 Women
Obesity (reference normal BMI)
 Men
 Women
87 716
48 791
37 238
46 447
39 655
38 162
39 794
45 353
33 151
37 864
41 034
44 340
131 882
136 680
9 835 775
9 538 159
3 150 820
5 271 704
3 089 811
3 749 493
3 029 468
4 941 600
2 808 575
4 649 162
3 184 326
4 752 337
17 632 210
22 310 188
619 402
592 157
276 686
423 861
262 745
325 540
259 265
398 992
235 245
363 666
273 190
391 681
636 779
815 005
 (1·38–1·45)
 (1·28–1·39)
 (2·06–2·29)
 (1·91–2·14)
 (1·56–1·83)
 (1·73–2·03)
 (1·50–1·70)
 (1·48–1·67)
 (1·38–1·64)
 (1·49–1·92)
 (1·24–1·36)
 (1·21–1·36)
 (0·98–1·11)
 (1·10–1·24)
 1·42
 1·34
 2·17
 2·02
 1·69
 1·88
 1·60
 1·58
 1·50
 1·69
 1·30
 1·28
 1·04
 1·17
1·50·5 1·52·01·0
Mutually adjusted
HR (95% CI)
Risk factor and 
outcomes
Low SES (reference high SES)
 All-cause
 CVD
 Cancer
 Other
Current smoking (reference never smoking)
 All-cause
 CVD
 Cancer
 Other
Diabetes
 All-cause
 CVD
 Cancer
 Other
Physical inactivity
 All-cause
 CVD
 Cancer
 Other
High alcohol intake (reference moderate intake)
 All-cause
 CVD
 Cancer
 Other
Hypertension
 All-cause
 CVD
 Cancer
 Other
Obesity (reference normal BMI)
 All-cause
 CVD
 Cancer
 Other
 1·26 (1·21–1·32)
 1·29 (1·16–1·43)
 1·26 (1·19–1·34)
 1·25 (1·17–1·33)
 2·21 (2·10–2·33)
 2·21 (2·00–2·44)
 2·52 (2·32–2·74)
 1·99 (1·85–2·14)
 1·73 (1·60–1·88)
 1·92 (1·64–2·27)
 1·18 (1·04–1·34)
 2·08 (1·91–2·26)
 1·28 (1·19–1·37)
 1·35 (1·25–1·46)
 1·14 (1·06–1·23)
 1·34 (1·22–1·47)
 1·36 (1·23–1·51)
 1·19 (1·08–1·32)
 1·38 (1·21–1·56)
 1·46 (1·30–1·65)
 1·31 (1·24–1·38)
 1·69 (1·53–1·88)
 1·07 (0·99–1·16)
 1·29 (1·21–1·38)
 1·05 (0·97–1·14)
 1·22 (1·06–1·40)
 1·02 (0·94–1·11)
 1·01 (0·92–1·10)
Minimally adjusted
HR (95% CI)
 1·46 (1·39–1·53)
 1·52 (1·37–1·67)
 1·43 (1·34–1·52)
 1·45 (1·35–1·56)
 2·27 (2·14–2·39)
 2·19 (1·98–2·42)
 2·64 (2·40–2·91)
 2·05 (1·91–2·20)
 1·87 (1·72–2·03)
 2·18 (1·86–2·55)
 1·21 (1·06–1·38)
 2·21 (2·01–2·42)
 1·43 (1·34–1·53)
 1·54 (1·43–1·65)
 1·25 (1·15–1·36)
 1·50 (1·37–1·64)
 1·64 (1·44–1·87)
 1·45 (1·26–1·66)
 1·70 (1·44–1·99)
 1·76 (1·52–2·03)
 1·38 (1·30–1·46)
 1·83 (1·66–2·03)
 1·08 (0·98–1·18)
 1·38 (1·28–1·47)
 1·18 (1·09–1·27)
 1·46 (1·28–1·66)
 1·01 (0·92–1·10)
 1·17 (1·08–1·26)
2·01·00·5 3·02·51·5
Figure 4: Pooled hazard ratios of socioeconomic status and 25 × 25 risk factors for all-cause mortality and 
cause-specific mortality 
The minimally adjusted models were only adjusted for sex, age, and race or ethnicity; in the mutually adjusted 
models, SES and the 25 × 25 risk factors are mutually adjusted. BMI=body-mass index. CVD=cardiovascular disease. 
SES=socioeconomic status.
Figure 3: Pooled hazard ratios of socioeconomic status and 25 × 25 risk factors for mortality
HRs are adjusted for age, marital status, and race or ethnicity. SES=socioeconomic status. BMI=body-mass index.
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leading to weight loss and increased mortality risk 
among lean or underweight individuals.31,32 Hetero-
geneity in study-specific estimates was generally low 
for occupational position, but larger for some of the 
risk factors (appendix). This difference could be due to 
varying degrees of precision in the measurement of the 
25 × 25 risk factors in the different cohorts, and random-
effect meta-analysis partially takes this uncertainty into 
account for the estimation of pooled effects. 
Finally, the cohort studies participating in the 
LIFEPATH consortium were from high-income 
countries. Thus, our results might not be generalisable 
to other populations. Previous studies suggest that 
socio economic factors and the 25 × 25 risk factors are 
also strong predictors of premature mortality in low 
and middle income countries.33 Further research should 
assess socioeconomic status and 25 × 25 risk factors in 
predicting mortality in different economic settings.
Despite these limitations, our study has important 
implications. Our findings suggest that existing global 
strategies and actions defined in the 25 × 25 health plan 
and the Global Burden of Diseases surveillance 
programme potentially exclude a major determinant of 
health from the agenda. A lack of consideration of the 
interrelation between social circumstances and health is 
also evident in the Sustainable Development Goals 
(SDGs): SDG 3 focuses on health but it makes no 
mention of the role of social circumstances. Similarly, 
SDG 1 and 4 focus on the elimination of poverty and the 
achievement of universal primary education but they do 
not mention reducing health inequalities as an explicit 
goal. Similar to the risk factors targeted by existing 
global health strategies, socioeconomic circumstances 
are modifiable by policies at the local, national, and 
international levels,26,34 through interventions such as 
promotion of early childhood development, poverty 
reduction, improve ments to access to high-quality 
education, enacting of compulsory schooling laws, and 
creation of safe home, school, and work environments.8,9 
Over the past decade, socioeconomic factors have 
started making their way into international agencies 
and global reports, as evidenced in the report of the 
WHO Commission on the Social Determinants of 
Health (CSDH) in 200826 and in the Rio Political 
Declaration on the Social Determinants of Health.35 
Although these efforts have raised awareness of 
socioeconomic inequalities in health, global prevention 
strategies still appear to be centred on the treatment of 
proximal risk factors. Such approaches fail to address 
powerful upstream structural solutions such as 
investment in early education programmes for children 
(allowing parents to work while their children are cared 
for) and work incentive programmes (ie, earned income 
tax credit) that might be a cost-effective way to reduce 
inequalities in health.10,36–38 By showing low 
socioeconomic status has a comparable health effect to 
that of major risk factors, the results of our study 
suggest that socio economic circumstances, in addition 
to the 25 × 25 factors, should be treated as a target for 
local and global health strategies, health risk 
surveillance, interventions, and policy.
PAF (95% CI)Prevalence (%)Risk factor
Low SES (intermediate/low)
 Men
 Women
Current smoking (former/current)
 Men
 Women
Diabetes
 Men
 Women
Physical inactivity
 Men
 Women
High alcohol intake
 Men
 Women
Hypertension
 Men
 Women
Obesity (overweight/obese)
 Men
 Women
 25·1/42·4
 45·8/28·1
 32·8/27·1
 20·9/21·0
 9·4
 8·7
 39·5
 46·2
 10·0
 4·8
 38·0
 31·4
 43·9/19·4
 28·9/22·0
 (17·63 to 20·24)
 (12·76 to 17·90)
 (26·90 to 31·18)
 (19·02 to 23·07)
 (4·85 to 7·00)
 (5·76 to 8·00)
 (23·01 to 29·31)
 (20·42 to 26·39)
 (3·26 to 5·42)
 (2·34 to 4·20)
 (7·92 to 11·60)
 (6·22 to 10·20)
 (−8·84 to −2·31)
 (1·35 to 5·74)
 18·94
 15·33
 29·04
 21·04
 5·93
 6·88
 26·16
 23·41
 4·34
 3·27
 9·76
 8·21
 −5·57
 3·55
10
Population attributable fraction (%)
–10 4020 200
Figure 5: Population attributable fraction for socioeconomic status and 25 × 25 risk factors
Calculations assume risk in the population at the level of the least exposed group. SES=socioeconomic status. 
PAF=population attributable fraction.
Figure 6: Life expectancy from age 40 years to 85 years and years of life lost due to low socioeconomic status 
and 25 × 25 risk factors 
SES=socioeconomic status. BMI=body-mass index.
20
25
30
35
40
45
Li
fe
 e
xp
ec
ta
nc
y 
(y
ea
rs
)
–2·6 (–2·8 to –2·4) –5·6 (–6·1 to –5·2) –4·1 (–4·7 to –3·4) –2·8 (–3·4 to –2·2) –0·6 (–1·1 to –0·1) –1·9 (–2·3 to –1·6) –0·4 (–0·8 to 0·1)
Men
Years of life lost (95% CI)
20
25
30
35
40
45
Li
fe
 e
xp
ec
ta
nc
y 
(y
ea
rs
)
Hig
h
Lo
w
SES
–1·5 (–1·8 to –1·3) –4·0 (–4·5 to –3·6) –3·9 (–4·6 to –3·2) –2·0 (–2·5 to –1·5) –0·4 (–0·8 to 0·0) –1·3 (–1·7 to –1·0) –0·9 (–1·3 to –0·6)
Ne
ve
r
Cu
rre
nt
Smoking
No Ye
s
Diabetes
No Ye
s
Physical
inactivity
Mo
de
rat
e
Hig
h
Alcohol intake
No Ye
s
Hypertension
No
rm
al
Ob
ese
BMI
Women
Years of life lost (95% CI)
Articles
1236 www.thelancet.com   Vol 389   March 25, 2017
Contributors
MK, SS, and PV conceived the study. SS wrote the first and successive 
drafts of the manuscript. CC and MJ modelled and analysed the data. 
CC, MA, JPM, PM, CD, IK, MK-I, RL, AS, MC-H, and Ad’E contributed 
to study conception and design. FG and FR contributed to data analysis. 
HB, MB, FC-C, GC, SF, MG, GGG, VK, AML, MGM, MP, MJS, AS, PV, 
MZ, MK, PV, and MJ collected the data. All authors revised the 
manuscript for important intellectual content.
LIFEPATH Consortium
Harri Alenius, Mauricio Avendano, Henrique Barros, Murielle Bochud, 
Cristian Carmeli, Luca Carra, Raphaele Castagné, Marc Chadeau-Hyam, 
Françoise Clavel-Chapelon, Giuseppe Costa, Emilie Courtin, 
Cyrille Delpierre, Angelo D’Errico, Pierre-Antoine Dugué, Paul Elliott, 
Silvia Fraga, Valérie Gares, Graham Giles, Marcel Goldberg, 
Dario Greco, Allison Hodge, Michelle Kelly Irving, Piia Karisola, 
Mika Kivimäki, Vittorio Krogh, Thierry Lang, Richard Layte, 
Benoit Lepage, Johan Mackenbach, Michael Marmot, Cathal McCrory, 
Roger Milne, Peter Muennig, Wilma Nusselder, Salvatore Panico, 
Dusan Petrovic, Silvia Polidoro, Martin Preisig, Olli Raitakari, 
Ana Isabel Ribeiro, Ana Isabel Ribeiro, Fulvio Ricceri, Oliver Robinson, 
Jose Rubio Valverde, Carlotta Sacerdote, Roberto Satolli, Gianluca Severi, 
Martin J Shipley, Silvia Stringhini, Rosario Tumino, Paolo Vineis, 
Peter Vollenweider, and Marie Zins.
Declaration of interests
PVo reports grants from GlaxoSmithKline. JPM reports grants from 
European Commission. MK reports grants from the Medical Research 
Council and NordForsk, the Nordic Research Programme on Health and 
Welfare. MP reports grants from GlaxoSmithKline and Swiss National 
Science Foundation, during the conduct of the study. All other authors 
declare no competing interests.
Acknowledgments
This study was partly supported by the European Commission 
(Horizon 2020 grant number 633666) and the Swiss State Secretariat 
for Education, Research and Innovation SERI. SS is supported by an 
Ambizione Grant (PZ00P3_167732) from the Swiss National Science 
Foundation. SF is supported by the Portuguese Foundation for Science 
and Technology (SFRH/BPD/97015/2013). AML is supported by an 
MD-PhD grant (323530_151479) from the Swiss National Science 
Foundation. Various sources have supported recruitment, follow-up, 
and measurements in the 48 cohort studies contributing to this 
collaborative analysis. MK is supported by the UK Medical Research 
Council (K013351) and NordForsk.
References
1 WHO. Global action plan for the prevention and control of 
noncommunicable diseases 2013–2020. Geneva, Switzerland: World 
Health Organization, 2013.
2 Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment 
of burden of disease and injury attributable to 67 risk factors and 
risk factor clusters in 21 regions, 1990–2010: a systematic analysis 
for the Global Burden of Disease Study 2010. Lancet 2012; 
380: 2224–60.
3 Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic 
inequalities in health in 22 European countries. N Engl J Med 2008; 
358: 2468–81.
4 Stringhini S, Sabia S, Shipley M, et al. Association of socioeconomic 
position with health behaviors and mortality. JAMA 2010; 303: 1159–66.
5 Stringhini S, Rousson V, Viswanathan B, Gedeon J, Paccaud F, 
Bovet P. Association of socioeconomic status with overall and cause 
specific mortality in the Republic of Seychelles: results from a 
cohort study in the African region. PLoS One 2014; 9: e102858.
6 Hosseinpoor AR, Bergen N, Mendis S, et al. Socioeconomic 
inequality in the prevalence of noncommunicable diseases in 
low- and middle-income countries: results from the World Health 
Survey. BMC Public Health 2012; 12: 474.
7 Rasella D, Aquino R, Santos CA, Paes-Sousa R, Barreto ML. 
Effect of a conditional cash transfer programme on childhood 
mortality: a nationwide analysis of Brazilian municipalities. 
Lancet 2013; 382: 57–64.
8 Lleras-Muney A. The relationship between education and adult 
mortality in the United States. Rev Econ Stud 2005; 72: 189–221.
9 Heckman JJ. Skill formation and the economics of investing in 
disadvantaged children. Science 2006; 312: 1900–02.
10 Lopez-Arana S, Avendano M, van Lenthe FJ, Burdorf A. The impact 
of a conditional cash transfer programme on determinants of child 
health: evidence from Colombia. Public Health Nutr 2016; 19: 1–14.
11 Stringhini S, Viswanathan B, Gedeon J, Paccaud F, Bovet P. 
The social transition of risk factors for cardiovascular disease in the 
African region: Evidence from three cross-sectional surveys in the 
Seychelles. Int J Cardiol 2013; 168: 1201–06.
12 Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic 
Reviews of Interventions Version 5.1.0 [updated March 2011]. 
The Cochrane Collaboration, 2011. http://www.handbook.cochrane.
org (accessed June 15, 2016).
13 Royston P, Parmar MK. Flexible parametric proportional-hazards 
and proportional-odds models for censored survival data, with 
application to prognostic modelling and estimation of treatment 
effects. Stat Med 2002; 21: 2175–97.
14 WHO. Metrics: Population Attributable Fraction (PAF). Quantifying 
the contribution of risk factors to the Burden of Disease. 2016. 
http://www.who.int/healthinfo/global_burden_disease/metrics_
paf/en/2016 (accessed June 15, 2016).
15 IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-
Jonkman method for random effects meta-analysis is 
straightforward and considerably outperforms the standard 
DerSimonian-Laird method. BMC Med Res Methodol 2014; 14: 25.
16 IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely 
presenting prediction intervals in meta-analysis. BMJ Open 2016; 
6: e010247.
17 Muennig P, Fiscella K, Tancredi D, Franks P. The relative health 
burden of selected social and behavioral risk factors in the United 
States: implications for policy. Am J Public Health 2010; 100: 1758–64.
18 Muennig P, Franks P, Jia H, Lubetkin E, Gold MR. 
The income-associated burden of disease in the United States. 
Soc Sci Med 2005; 61: 2018–26.
19 Maki NE, Martikainen PT, Eikemo T, et al. The potential for 
reducing differences in life expectancy between educational 
groups in five European countries: the effects of obesity, physical 
inactivity and smoking. J Epidemiol Community Health 2014; 
68: 635–40.
20 Townsend P, Davidson N. Inequalities in health: The Black report. 
Harmondsworth, UK: Penguin Books, 1982.
21 Marmot MG, Shipley MJ, Rose G. Inequalities in death—specific 
explanations of a general pattern? Lancet 1984; 1: 1003–06.
22 Chetty R, Stepner M, Abraham S, et al. The Association between 
income and life expectancy in the United States, 2001–2014. 
JAMA 2016; 315: 1750–66.
23 Mackenbach JP, Kulhanova I, Artnik B, et al. Changes in mortality 
inequalities over two decades: register based study of European 
countries. BMJ 2016; 353: i1732.
24 Stringhini S, Dugravot A, Shipley M, et al. Health behaviours, 
socioeconomic status, and mortality: further analyses of the British 
Whitehall II and the French GAZEL prospective cohorts. PLoS Med 
2011; 8: e1000419.
25 Mayhew L, Smith D. An investigation into inequalities in adult 
lifespan. London, UK: Cass Business School, City University 
London, 2016.
26 Commission for the Social Determinants of Health. Closing the gap in 
a generation: health equity through action on the social determinants 
of health. Final Report of the Commission on Social Determinants of 
Health. Geneva: World Health Organization, 2008.
27 Gellert C, Schottker B, Brenner H. Smoking and all-cause mortality 
in older people: systematic review and meta-analysis. 
Arch Intern Med 2012; 172: 837–44.
28 Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, 
de Gaetano G. Alcohol dosing and total mortality in men and 
women: an updated meta-analysis of 34 prospective studies. 
Arch Intern Med 2006; 166: 2437–45.
29 Nocon M, Hiemann T, Muller-Riemenschneider F, Thalau F, Roll S, 
Willich SN. Association of physical activity with all-cause and 
cardiovascular mortality: a systematic review and meta-analysis. 
Eur J Cardiovasc Prev Rehabil 2008; 15: 239–46.
30 Seshasai SR, Kaptoge S, Thomson A, et al, for Emerging Risk 
Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of 
cause-specific death. N Engl J Med 2011; 364: 829–41.
Articles
www.thelancet.com   Vol 389   March 25, 2017 1237
31 Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass 
index and mortality among 1·46 million white adults. N Engl J Med 
2010; 363: 2211–19.
32 Whitlock G, Lewington S, Sherliker P, et al, for the Prospective 
Studies Collaboration. Body-mass index and cause-specific mortality 
in 900 000 adults: collaborative analyses of 57 prospective studies. 
Lancet 2009; 373: 1083–96.
33 Di Cesare M, Khang YH, Asaria P, et al. Inequalities in 
non-communicable diseases and effective responses. Lancet 2013; 
381: 585–97.
34 Marmot MG, Atkinson T, Bell J, et al. Fair society, healthy lives: 
a strategic review of health inequalities in England post-2010: 
The Marmot Review. London: UCL Institute, 2010.
35 WHO. Rio Political Declaration on Social Determinants of Health. 
Rio de Janeiro, Brazil: World Health Organization, 2011.
36 Levin H, Belfield C, Muennig P, Rouse C. The costs and benefits of 
an excellent education for America’s children. New York, NY: 
Teachers College, 2006.
37 Elesh D, Lefcowitz MJ. The effects of the New Jersey-Pennsylvania 
Negative Income Tax Experiment on health and health care 
utilization. J Health Soc Behav 1977; 18: 391–405.
38 Muennig PA, Mohit B, Wu J, Jia H, Rosen Z. Cost effectiveness of 
the earned income tax credit as a health policy investment. 
Am J Prev Med 2016; published online Aug 26. DOI:10.1016/ 
j.amepre.2016.07.001.
